Foundry120 atlas

Public scientific datasets, scored for reuse.

Atlas continuously monitors published datasets and assesses their reusability.

Dataset explorer

Rank by Impact Reuse Largest cohort
# Dataset Participants Samples Reuse Impact
1 IBDverse multitissue atlasing cohort

10x Genomics Chromium · open

421 732 8.9 /10 3,746.9
2 Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy

Illumina HiSeq 2000 · unknown

199 199 6.0 /10 1,194.0
3 IPF Cell Atlas

Illumina HiSeq 4000 · unknown

78 78 7.1 /10 553.8
4 Human CD atlas study between colon and terminal ileum

10x 3' v1 · open

71 — 6.7 /10 475.7
5 Reveal the key mediators of inflammation in Crohn's disease undergoing biological treatments

GPL24676 and GPL18573 · unknown

49 85 7.6 /10 372.4
6 An immune-cell signature of bacterial sepsis (Patient PBMCs)

single-cell-portal-scp548 · open

45 — 6.9 /10 310.5
7 TI epithelial

10x Genomics · open

42 — 6.0 /10 252.0
8 Processed bulk RNA-seq counts and Olink Explore 384 NPX data from tofacitinib-treated patients with ulcerative colitis (TOFA-histology multi-omic substudy)

bulk RNA-seq and Olink Explore 384 proteomics · open

40 — 6.1 /10 244.0
9 TI stromal

10x 3' v2 · open

40 — 5.7 /10 228.0
10 TL1A-activated Tcells as upstream regulators of perianal fistulizing disease-associated changes in the rectum of Crohn's Disease patients [scRNA-seq]

10x Genomics · unknown

31 29 7.1 /10 220.1

View all 85 Single cell datasets →

Impact = reuse-readiness mean (0–10) × participants; sample counts never affect it. Reuse readiness is not a measure of scientific validity.

Methodology

  1. 01

    Monitored daily

    Sources are checked every day.

  2. 02

    Extract key metadata

    Structured data extracted programmatically and with LLM for completeness.

  3. 03

    Score & publish

    Each dataset is scored 0–10 on multiple dimensions for reuse readiness then published.

Sources

How datasets are scored

Each dataset is scored 0–10 on each dimension below and the mean is the reuse-readiness score.

Cohort clarity

Participants, disease groups and controls are stated, each with evidence.

Sample traceability

Samples can be traced to an anatomical site, a specimen type, and a participant.

Data completeness

Raw counts, processed matrices, coordinates, images and metadata are deposited.

Internal consistency

Sources agree; conflicting claims cost points until resolved.

Accessibility

The data is openly deposited or has a documented access route.

Additional dataset-specific metrics


DomainAdditional dimensions
IBD spatial transcriptomics

Technical completeness: Platform, resolution, panel scope and segmentation method are documented.

Reproducibility: Analysis code, run environment, reference files and a file manifest are available.
IBD microbiome

Sequencing completeness: Platform, assay type and sequencing targets are documented.

Reproducibility: Analysis code, run environment, reference files and a file manifest are available.
IBD single-cell transcriptomics

Assay documentation: Assay class, platform, library chemistry and reference genome are documented.

Processing reproducibility: QC, doublet detection, normalization and annotation methods are reported.